Obesity as a risk factor for adverse outcomes after pedestrian trauma accidents in the pediatric population - Mulvihill H, Roster K, Lakhi N.
OBJECTIVE: The aim of the study is to determine whether overweight or obese children are at an increased risk for injury and adverse outcomes following pedestrian motor vehicle accidents. METHODS: We performed a retrospective study of patients betw... (Source: SafetyLit)
Source: SafetyLit - May 10, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Kids and Anti-Obesity Meds: Real-World Challenges Kids and Anti-Obesity Meds: Real-World Challenges
The new anti-obesity drugs could be as beneficial for the treatment of adolescents as adults — but obstacles may require creative strategies.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
EVgo's Q1 Performance Sparks Optimism, Analyst Upgrades Stock
Cantor Fitzgerald analyst Andres Sheppard upgraded the shares of EVgo Inc EVGO from Neutral to Overweight and lowered the price target from $5 to $4. EVGO reported a first-quarter FY24 sales jump of 118.2% year-on-year to $55.16 million, beating the analyst consensus estimate of $52.389 million.…#cantorfitzgerald #andressheppard #evgoincevgo #neutral #evgo #olgashevorenkova #yyevgo #plugshare #breakevenadj #nevi (Source: Reuters: Health)
Source: Reuters: Health - May 9, 2024 Category: Consumer Health News Source Type: news
Bariatric Surgery Tied to Higher Short-Term Risk for Venous Thromboembolism
THURSDAY, May 9, 2024 -- In the short term, bariatric surgery is associated with a greater risk for venous thromboembolism (VTE), but in the long-term, it is associated with lower risk, according to a study published online April 30 in Obesity... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2024 Category: Pharmaceuticals Source Type: news
The Land That Doesn ’ t Need Ozempic
In March 2023, the Japanese medical authorities announced that the new weight loss drug Wegovy—which was in staggering demand across the world, causing shortages everywhere—had been approved to treat obesity in their country. It sounded, at first glance, like great news for Novo Nordisk, the company that makes Ozempic and Wegovy. But industry outlet the Pharma Letter explained that this would not in fact turn out to be much of a boost. They predicted that these drugs would dominate the market in Japan, but that won’t mean much, for a simple reason: there is almost no obesity there. Some 42% of Americans a...
Source: TIME: Health - May 9, 2024 Category: Consumer Health News Authors: Johann Hari Tags: Uncategorized Books freelance Source Type: news
India's top nutrition institute declares mud pots best utensil for cooking, warns about non-stick pans
The National Institute of Nutrition (NIN) updates dietary guidelines for Indians, emphasizing the use of earthen cookware as safest for cooking due to its eco-friendliness and food preservation qualities. NIN also issues warnings about unsafe storage of acidic foods in metal vessels and overheating non-stick pans. Additionally, guidelines recommend limiting sugar intake, avoiding protein supplements, and promoting healthier dietary habits to combat malnutrition and obesity. (Source: The Economic Times)
Source: The Economic Times - May 9, 2024 Category: Consumer Health News Source Type: news
New weight loss 'game changer' silences hunger and lasts longer than Ozempic
An experimental new weight loss surgery performed in North Carolina that helped patients overcome their hunger hormones has the potential to change the way people treat obesity. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2024 Category: Consumer Health News Source Type: news
New oral diabetes + obesity drug's India sales surge 100%
India experiences a surge in Rybelsus sales, impacting the anti-obesity market. Semaglutide dominates, reflecting India's obesity challenges and evolving disease patterns as it grows as a superpower. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 8, 2024 Category: Pharmaceuticals Source Type: news
Majority of Adults At Risk for CKM Syndrome Majority of Adults At Risk for CKM Syndrome
The creation of CKM syndrome by the American Heart Association in 2023 aimed to recognize the intricate interplay between heart, kidney diseases, diabetes, and obesity.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 8, 2024 Category: Cardiology Tags: Family Medicine/Primary Care Clinical Summary Source Type: news
Obesity 'game changer' in new procedure that burns lining of the stomach and destroys hunger hormone
An experimental new weight loss surgery performed in North Carolina that helped patients overcome their hunger hormones has the potential to change the way people treat obesity. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2024 Category: Consumer Health News Source Type: news
MRE-Liver Stiffness Measure Better for Varices in NAFLD Cirrhosis
WEDNESDAY, May 8, 2024 -- For patients with obesity and nonalcoholic fatty liver disease (NAFLD) compensated cirrhosis (CC), liver stiffness measurement (LSM) by magnetic resonance elastography (MRE) is significantly higher than acoustic radiation... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2024 Category: Pharmaceuticals Source Type: news
No One Knows How to Talk About Weight Loss Anymore
Jess, 38, has lost 75 pounds since she started taking Wegovy last year. She’s thrilled with the results—in addition to losing weight, her blood work and sleep apnea have improved—but the changes to her life and body feel too fraught to talk about with her friends, who want nothing to do with her weight loss.
Years ago, Jess, who asked to use only her first name for privacy, and her friends embraced the principles of the Health at Every Size movement, which fights against anti-fat bias and argues that weight is not an accurate indicator of health. But last summer, despite her support for that school of ...
Source: TIME: Health - May 8, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Evergreen healthscienceclimate Source Type: news
When'One Size' Doesn't Fit All When'One Size' Doesn't Fit All
Treating obesity requires more than a single solution for all patients. Sarah Ro, MD, and Asantewaa Crumpler, MD, discuss taking a more personalized approach with their patients.Medscape Diabetes & Endocrinology (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 8, 2024 Category: Cardiology Tags: Diabetes & Endocrinology Commentary Source Type: news
Symbotic Reports Q1 Beat: Analysts Boost Their 2024 Estimates,'Strong Secular Growth Story '
Symbotic Inc (NASDAQ:SYM) shares were climbing in early trading on Tuesday, after the company reported a sales beat for its fiscal second quarter. The results were reported amid an exciting earnings season. Here are some key analyst expectations. Analyst Ken Newman maintained an Overweight rating…#symboticinc #sym #kennewman #overweight #newman #greenboxjv #ricchiuti #fq3 #consensus44 #sympriceaction (Source: Reuters: Health)
Source: Reuters: Health - May 8, 2024 Category: Consumer Health News Source Type: news
Excess Gestational Weight Gain Common in Military Health Beneficiaries
TUESDAY, May 7, 2024 -- Military health beneficiaries, especially active-duty personnel, more often have excessive gestational weight gain (GWG), according to a study published in the May issue of Obesity.Rebecca A. Krukowski, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2024 Category: Pharmaceuticals Source Type: news
